The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2025

Filed:

Oct. 27, 2021
Applicant:

Lipocine Inc., Salt Lake City, UT (US);

Inventors:

Kilyoung Kim, Salt Lake City, UT (US);

Nachiappan Chidambaram, Salt Lake City, UT (US);

Mahesh V. Patel, Salt Lake City, UT (US);

Benjamin J. Bruno, Salt Lake City, UT (US);

Shadi Mehraban, Salt Lake City, UT (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/573 (2006.01); A61K 9/00 (2006.01); A61P 15/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/573 (2013.01); A61K 9/0053 (2013.01); A61P 15/06 (2018.01);
Abstract

An HPC composition and method of treatment for the prevention of PTB and improved neonatal outcomes. The invention provides for a dosing regimen beginning as early as 14 weeks of fetal gestation and dosing regimens of a duration of as much as 25 weeks. The invention provides a high level of exogeneous progestin to endogenous progesterone when it is most needed. The instant invention consistently achieves active levels of HPC which achieve effectiveness. Exemplary dosing regimens comprise an oral administration of HPC in the range of 1,200 mg to 1600 mg, wherein the HPC is administered via a once a day, twice a day, or three times a day administration.


Find Patent Forward Citations

Loading…